The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. 2004

Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
Department of Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Greifswald, Germany.

Platelet aggregation is initiated by the release of mediators as adenosine diphosphate (ADP) stored in platelet granules. Possible candidates for transport proteins mediating accumulation of these mediators in granules include multidrug resistance protein 4 (MRP4, ABCC4), a transport pump for cyclic nucleotides and nucleotide analogs. We investigated the expression of MRP4 in human platelets by immunoblotting, detecting a strong signal at 170 kDa. Immunofluorescence microscopy using 2 MRP4-specific antibodies revealed staining mainly in intracellular structures, which largely colocalized with the accumulation of mepacrine as marker for delta-granules and to a lower extent at the plasma membrane. Furthermore, an altered distribution of MRP4 was observed in platelets from a patient with Hermansky-Pudlak syndrome with defective delta-granules. Adenosine triphosphate (ATP)-dependent cyclic guanosine monophosphate (cGMP) transport codistributed with MRP4 detection in subcellular fractions, with highest activities in the dense granule and plasma membrane fractions. This transport was inhibited by dipyramidole, indomethacin, and MK571 with median inhibitory concentration (IC(50)) values of 12, 22, and 43 microM, and by ibuprofen. Transport studies with [(3)H]ADP indicated the presence of an orthovanadate-sensitive ADP transporting system, inhibited by dipyramidole, MK571, and cyclic nucleotides. The results indicate a function of MRP4 in platelet mediator storage and inhibition of MRP4 may represent a novel mechanism for inhibition of platelet function by some anti-inflammatory drugs.

UI MeSH Term Description Entries
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D014638 Vanadates Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects. Decavanadate,Metavanadate,Orthovanadate,Oxyvanadium,Vanadyl,Monovanadate,Sodium Vanadate,Vanadate,Vanadate, Sodium
D022142 Secretory Vesicles Vesicles derived from the GOLGI APPARATUS containing material to be released at the cell surface. SLMVs,Secretory Granules,Synaptic Like Microvesicles,Synaptic-Like Microvesicles,Zymogen Granules,Condensing Vacuoles,Condensing Vacuole,Granule, Secretory,Granule, Zymogen,Microvesicle, Synaptic-Like,Secretory Granule,Secretory Vesicle,Synaptic Like Microvesicle,Synaptic-Like Microvesicle,Vacuole, Condensing,Vesicle, Secretory,Zymogen Granule
D022861 Hermanski-Pudlak Syndrome Syndrome characterized by the triad of oculocutaneous albinism (ALBINISM, OCULOCUTANEOUS); PLATELET STORAGE POOL DEFICIENCY; and lysosomal accumulation of ceroid lipofuscin. Hermansky-Pudlak Syndrome,Hermanski Pudlak Syndrome,Hermansky Pudlak Syndrome
D027425 Multidrug Resistance-Associated Proteins A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey drug resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance (DRUG RESISTANCE, MULTIPLE). Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 family of proteins. Multidrug Resistance-Associated Protein,ATP-Binding Cassette, Sub-Family C Proteins,MOAT Protein,Multispecific Organic Anion Transport Proteins,Multispecific Organic Anion Transporter,ATP Binding Cassette, Sub Family C Proteins,Multidrug Resistance Associated Protein,Multidrug Resistance Associated Proteins,Resistance-Associated Protein, Multidrug

Related Publications

Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
March 2010, The American journal of pathology,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
September 2022, Haematologica,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
January 1984, Biochemistry,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
October 2014, Pharmacogenetics and genomics,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
January 2017, Thrombosis and haemostasis,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
January 1984, Biochemistry,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
January 2012, Frontiers in oncology,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
May 1978, The Journal of cell biology,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
June 2008, The Journal of pharmacology and experimental therapeutics,
Gabriele Jedlitschky, and Konstanze Tirschmann, and Lena E Lubenow, and Hendrik K Nieuwenhuis, and Jan W N Akkerman, and Andreas Greinacher, and Heyo K Kroemer
November 1968, The American journal of pathology,
Copied contents to your clipboard!